Johnson & Johnson Services, Inc.

产品通知表面上像是一块狭窄的安全管理，但对于受监管的健康产品集团而言，它也是一种商业工具：它告诉医院、临床医生、分销商、患者和监管机构哪些信息是官方信息，需要采取什么行动，如何解读证据，以及在基础产品已经投入使用的情况下责任归属何处。

A product notice looks like a narrow piece of safety administration, but for a regulated health-products group it is also a commercial instrument: it tells hospitals, clinicians, distributors, patients and regulators which message is official, what action is required, how the evidence should be interpreted and where responsibility sits when the underlying product is already in use.